John McCabe is Portfolio Company Chief Financial and Chief Operating Officer at Longwood Fund and has served as the CFO/COO of Longwood-founded companies Newleos Therapeutics, Inc., Solu Therapeutics, Inc., Weaver Biosciences, Inc. and DEM Biosciences, Inc. Prior to Longwood Fund, John served as CFO of Oncorus, Inc. Before joining Oncorus, John served in various roles including CFO of Flex Pharma, Inc., Vice President and Chief Accounting Officer at ARIAD Pharmaceuticals, Inc., Vice President and Corporate Controller at Charles River Associates and Director and Strategic Business Unit Controller at Biogen. John began his career at Arthur Andersen & Co. and later held financial positions at Performance Technologies, Inc. and IP.com.
John holds B.S. degrees in accounting and management information systems from Babson College and an M.B.A from the University of Massachusetts at Amherst.